{
    "clinical_study": {
        "@rank": "80568", 
        "acronym": "UTAPE BPCO", 
        "arm_group": {
            "arm_group_label": "AECOPD Mr proADM", 
            "arm_group_type": "No Intervention", 
            "description": "Patients involved in this study will have a simple blood sample collected for Mr proADM assessment at the end of study"
        }, 
        "brief_summary": {
            "textblock": "The purpose of this study is to determine whether pro-adrenomedullin (Mr proADM)in addition\n      to clinical evaluation is effective to predict outcome of acute exacerbations of COPD\n      patients visiting the emergency room(ER)."
        }, 
        "brief_title": "Prognosis Value of Pro-adrenomedullin in Acute Exacerbations of COPD in ER", 
        "completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "COPD Patients Admitted in ER for Acute Exacerbation", 
        "condition_browse": {
            "mesh_term": "Pulmonary Disease, Chronic Obstructive"
        }, 
        "detailed_description": {
            "textblock": "Acute exacerbation of COPD (AECOPD)are usual and frequent cause of admission in emergency\n      room (ER). No validated clinical or biological predictor of evolution are available.\n\n      The main objective is to determine the prognosis value of Mr proADM in addition to the\n      clinical risk stratification for AE COPD patients in ER.\n\n      Patients presenting with a AECOPD diagnosis in ER will have a blood sample collected and\n      freezed at their admission. Mr proADM will be assessed at the end of the study. Clinicians\n      in charge of patients will not have the result during the management of their patients. This\n      study implies no change in the patients' management.\n\n      Data related to the patients'demographic,current exacerbation and basic COPD characteristics\n      will be collected."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  patients > 40 years old\n\n          -  Acute exacerbation of COPD\n\n        Exclusion Criteria:\n\n          -  Medico social conditions not allowing home discharge\n\n          -  Other causes of Dyspnea: Pneumothorax, pulmonary embolism, pulmonary oedema, lung\n             cancer\n\n          -  Pneumonia on chest ray\n\n          -  acute respiratory distress requiring immediate ICU transfer"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "40 Years"
        }, 
        "enrollment": {
            "#text": "370", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 16, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01857947", 
            "org_study_id": "UTAPE01"
        }, 
        "intervention": {
            "arm_group_label": "AECOPD Mr proADM", 
            "intervention_name": "AECOPD Mr proADM", 
            "intervention_type": "Other"
        }, 
        "intervention_browse": {
            "mesh_term": "Adrenomedullin"
        }, 
        "is_fda_regulated": "No", 
        "keyword": "AECOPD Mr ProADM Biomarkers ER Outcome", 
        "lastchanged_date": "May 17, 2013", 
        "location": [
            {
                "contact": {
                    "email": "patrick.plaisance@lrb.aphp.fr", 
                    "last_name": "Patrick Plaisance, MD PHD", 
                    "phone": "+33149956391"
                }, 
                "facility": {
                    "address": {
                        "city": "Paris", 
                        "country": "France", 
                        "zip": "75010"
                    }, 
                    "name": "H\u00f4pital Lariboisi\u00e8re"
                }, 
                "investigator": {
                    "last_name": "Patrick Plaisance, MD PHD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "pierre.hausfater@psl.aphp.fr", 
                    "last_name": "Pierre Hausfater, MD PHD", 
                    "phone": "+33142177240"
                }, 
                "facility": {
                    "address": {
                        "city": "Paris", 
                        "country": "France", 
                        "zip": "75013"
                    }, 
                    "name": "Piti\u00e9 Salp\u00e9tri\u00e8re Hospital"
                }, 
                "investigator": {
                    "last_name": "Pierre Hausfater, MD PHD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_arms": "1", 
        "official_title": "Usefulness of Pro-adrenomedullin (MR proADM)as a Predictor of Outcome in Acute Exacerbations of COPD Visiting the Emergency Room", 
        "overall_contact": {
            "email": "patrick.plaisance@lrb.aphp.fr", 
            "last_name": "Patrick Plaisance, Pr MD", 
            "phone": "+331 49956391"
        }, 
        "overall_official": [
            {
                "affiliation": "Hotel Dieu Hospital Paris", 
                "last_name": "Nicolas Roche, MD PHD", 
                "role": "Study Chair"
            }, 
            {
                "affiliation": "Hopital Bic\u00eatre Le Kr\u00e9mlin Bic\u00eatre", 
                "last_name": "Martin Dres, MD", 
                "role": "Study Director"
            }, 
            {
                "affiliation": "Piti\u00e9 Salp\u00e9tri\u00e8re Hospital Paris", 
                "last_name": "Pierre Hausfater, MD PHD", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "France: Ministry of Health", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "April 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Death, subsequently transfer to ICU, relapse, need to be ventilated after 24 hours of their admission in ER", 
            "measure": "composite outcome measure", 
            "safety_issue": "No", 
            "time_frame": "at Day 30"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01857947"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Death, subsequently transfer to ICU, relapse, need to be ventilated after 24 hours of their admission in ER", 
                "measure": "composite outcome", 
                "safety_issue": "No", 
                "time_frame": "at Day 7 of ER admission"
            }, 
            {
                "description": "Correlation between MR proADM and patient's severity", 
                "measure": "correlation between Mr proADM and patients Severity", 
                "safety_issue": "No", 
                "time_frame": "at Day 7 and Day 30 of ED admission"
            }
        ], 
        "source": "ThermoFisher Scientific Brahms Biomarkers France", 
        "sponsors": {
            "collaborator": {
                "agency": "Assistance Publique - H\u00f4pitaux de Paris", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "ThermoFisher Scientific Brahms Biomarkers France", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "March 2013", 
        "study_design": "Intervention Model: Single Group Assignment, Masking: Single Blind (Investigator), Primary Purpose: Diagnostic", 
        "study_type": "Interventional", 
        "verification_date": "May 2013"
    }
}